ACM
ABBV icon

Arlington Capital Management’s AbbVie ABBV Stock Holding History

Arlington Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Hold
1,380
– – 0.22% 68
2026
Q1 		$300K Hold
1,380
– – 0.17% 74
2025
Q4 		$315K Sell
1,380
-126
-8% -$28.7K 0.19% 65
2025
Q3 		$349K Hold
1,506
– – 0.22% 68
2025
Q2 		$280K Hold
1,506
– – 0.24% 66
2025
Q1 		$316K Hold
1,506
– – 0.24% 46
2024
Q4 		$268K Hold
1,506
– – 0.19% 67
2024
Q3 		$297K Buy
1,506
+202
+15% +$37.7K 0.24% 59
2024
Q2 		$224K Sell
1,304
-192
-13% -$31.8K 0.19% 67
2024
Q1 		$272K Hold
1,496
– – 0.23% 68
2023
Q4 		$232K Sell
1,496
-466
-24% -$67.9K 0.21% 79
2023
Q3 		$292K Sell
1,962
-85
-4% -$12.5K 0.31% 52
2023
Q2 		$276K Hold
2,047
– – 0.24% 69
2023
Q1 		$326K Sell
2,047
-130
-6% -$19.9K 0.31% 61
2022
Q4 		$352K Buy
2,177
+309
+17% +$47.4K 0.39% 52
2022
Q3 		$251K Buy
+1,868
New +$268K 0.62% 13
2022
Q2 		– Sell
-2,335
Closed -$379K – 3
2022
Q1 		$379K Hold
2,335
– – 1.54% 24
2021
Q4 		$316K Buy
+2,335
New +$276K 0.57% 54
2021
Q3 		– Sell
-2,457
Closed -$277K – 53
2021
Q2 		$277K Buy
2,457
+122
+5% +$13.7K 0.56% 45
2021
Q1 		$253K Sell
2,335
-788
-25% -$84.3K 0.46% 44
2020
Q4 		$335K Buy
+3,123
New +$300K 0.46% 46

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Arlington Capital Management's ABBV Position: Q2 2026 in Review

Arlington Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,380 shares worth $347K. The position accounts for 0.22% of the portfolio, ranked #68.

Arlington Capital Management first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $379K in Q1 2022. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Arlington Capital Management held 1,380 shares of AbbVie worth $347K as of Q2 2026.
  • Arlington Capital Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.22% of Arlington Capital Management's portfolio in Q2 2026, its #68 holding.
  • Arlington Capital Management first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Arlington Capital Management's AbbVie position peaked at $379K in Q1 2022.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Arlington Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.